The human homologue of macaque area V6A von Pitzalis, S., Sereno, M.I., Committeri, G., Fattori, P., Galati, G., Tosoni, A., Galletti, C.

Volltext

Hypoalbuminemia in COVID‐19: assessing the hypothesis for underlying pulmonary capillary leakage von Wu, M. A., Fossali, T., Pandolfi, L., Carsana, L., Ottolina, D., Frangipane, V., Rech, R., Tosoni, A., Lopez, G., Agarossi, A., Cogliati, C., Meloni, F., Marchini, B., Nebuloni, M., Catena, E., Colombo, R.

Volltext

Adjuvant chemotherapy in average-risk adult medulloblastoma patients improves survival: a long term study von Franceschi, E, Minichillo, S, Mura, A, Tosoni, A, Mascarin, M, Tomasello, C, Bartolini, S, Brandes, A A

Volltext

Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma: phase II study from gruppo italiano cooperativo di neuro-oncologia (GICNO) von Brandes, A A, Tosoni, A, Cavallo, G, Bertorelle, R, Gioia, V, Franceschi, E, Biscuola, M, Blatt, V, Crinò, L, Ermani, M

Volltext

Assessing storm surge risk under future sea-level rise scenarios: a case study in the North Adriatic coast von Rizzi, J., Torresan, S., Zabeo, A., Critto, A., Tosoni, A., Tomasin, A., Marcomini, A.

Volltext

Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Ne... von Brandes, Alba A, Tosoni, A, Franceschi, E, Blatt, V, Santoro, A, Faedi, M, Amistà, P, Gardiman, M, Labianca, R, Bianchini, C, Ermani, M, Reni, M

Volltext

Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO) von Franceschi, E, Cavallo, G, Lonardi, S, Magrini, E, Tosoni, A, Grosso, D, Scopece, L, Blatt, V, Urbini, B, Pession, A, Tallini, G, Crinò, L, Brandes, A A

Volltext

New Strategies for Treatment of Sepsis

Volltext

PO-134: Retrospective analysis of treatment outcomes of sinonasal malignancies. Our 22-year experience von Tarchini, P, Farneti, P, Bellusci, A, Sciarretta, V, Donini, E, Frezza, G, Tosoni, A, Brandes, A, Pasquini, E

Volltext

Manufacturing Refused Knowledge in the Age of Epistemic Pluralism: Discourses, Imaginaries, and Practices on the Border of Science von Neresini, Federico, Agodi, Maria Carmela, Crabu, Stefano, Tosoni, Simone

Volltext

The role of treatments in IDH mutant molecular astrocytomas von Minichillo, S., Franceschi, E., Mura, A., Tosoni, A., Tallini, G., Pession, A., Foschini, M., Bortolotti, C., Danieli, D., Talacchi, A., Cirillo, L., Di Battista, M., Genestreti, G., Bartolini, S., Paccapelo, A., Brandes, A.A.

Volltext

Primary Cutaneous Coccidioidomycosis in an Italian Nun Working in South America and Review of Published Literature von Tortorano, A. M., Carminati, G., Tosoni, A., Tintelnot, K.

Volltext

The role of clinical and molecular characteristics in low grade gliomas von Mura, A., Franceschi, E., Minichillo, S., Tosoni, A., Fioravanti, A., Talacchi, A., Volpin, L., Tallini, G., De Biase, D., Visani, M., Degli Esposti, R., Genestreti, G., Pizzolitto, S., Agati, R., Bortolotti, C., Bartolini, S., Paccapelo, A., Brandes, A.A.

Volltext

IDH mutant and 1p19q codeleted low grade gliomas: to treat or not to treat? von Tosoni, A., Franceschi, E., Mura, A., Minichillo, S., Pession, A., De Biase, D., Danieli, D., Pizzolitto, S., Fioravanti, A., Volpin, L., Agati, R., Genestreti, G., Degli Esposti, R., Bartolini, S., Paccapelo, A., Brandes, A.A.

Volltext

Temozolomide three weeks on and one week off as first line therapy for patients with recurrent or progressive low grade gliomas von Tosoni, A., Franceschi, E., Ermani, M., Bertorelle, R., Bonaldi, L., Blatt, V., Brandes, Alba A.

Volltext

How effective is BCNU in recurrent glioblastoma in the modern era? A phase II trial von BRANDES, A. A, TOSONI, A, AMISTA, P, NICOLARDI, L, GROSSO, D, BERTI, F, ERMANI, M

Volltext

Innovation Capacity and the City: The Enabling Role of Design von Concilio, Grazia, Tosoni, Ilaria

Volltext

A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated von Veronesi, U, Orecchia, R, Luini, A, Gatti, G, Intra, M, Zurrida, S, Ivaldi, G, Tosi, G, Ciocca, M, Tosoni, A, De Lucia, F

Volltext

Gender and MGMT methylation in glioblastoma patients: interactions in the PERNO prospective study von Franceschi, E., Tosoni, A., Depenni, R., Urbini, B., Faedi, M., Michiara, M., Biasini, C., Giombelli, E., Pavesi, G., Zanelli, F., Cavallo, M.A., Tosatto, L., Fioravanti, A., Zunarelli, E., Lanza, G., Bartolini, D., Silini, E.M., Brandes, A.A.

Volltext

Sagopilone (ZK-EPO, ZK 219477) for recurrent glioblastoma. A phase II multicenter trial by the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor Group von Stupp, R., Tosoni, A., Bromberg, J.E.C., Hau, P., Campone, M., Gijtenbeek, J., Frenay, M., Breimer, L., Wiesinger, H., Allgeier, A., van den Bent, M.J., Bogdahn, U., van der Graaf, W., Yun, H.J., Gorlia, T., Lacombe, D., Brandes, A.A.

Volltext